OpenScience.ink

1 week ago • Internal and emergency medicine

Semaglutide's effects on thinking skills in people with type 2 diabetes and mild memory problems over 24 monthsImpact of semaglutide on cognitive function in patients with type 2 diabetes and mild cognitive impairment: a 24-month observational study.

3 weeks ago • Diabetes & metabolism journal

Semaglutide and Exercise Together Help Keep Muscle and Reveal Organ Communication in ObesitySemaglutide and Exercise Synergy in Obesity: Preserving Muscle Mass and Uncovering Organ Crosstalk.

4 days ago • European journal of endocrinology

Safety of diabetes drugs that target GLP-1 receptors in hormone-related tumorsSafety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms.

Article

5 days ago • Cardiovascular diabetology. Endocrinology reports

Tirzepatide use in repeated pancreatitis caused by high triglycerides and type 2 diabetes: a case reportTirzepatide in recurrent hypertriglyceridemia-mediated pancreatitis and type 2 diabetes: a case report.

Article

6 days ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

Incretin-Based Medications and Their Effects on Women's Reproductive Health: Review and Clinical GuidelinesIncretin-Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice.

Article

1 week ago • Internal and emergency medicine

How GLP-1 receptor activators relate to diabetes, fatty liver disease, and liver cancerGLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma.

Article

1 week ago • Diabetes, obesity & metabolism

GLP-1 Medicines and Skin Cancer Risk in Adults with Type 2 DiabetesGLP-1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation.

Article

1 week ago • Aesthetic surgery journal. Open forum

Plastic Surgery Videos Related to GLP-1 on TikTok: A Snapshot StudyA Cross-Sectional Analysis of Plastic Surgery With GLP-1-Related Content on TikTok.

Article

1 week ago • Medicines (Basel, Switzerland)

Early Real-World Results of Semaglutide for Obesity Beyond Just Weight LossBeyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity.

1 week ago • Clinical case reports

Allergic reaction to tirzepatide with tolerance to semaglutide: a case reportHypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report.

2 weeks ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

Heart health effects of GLP-1 medicines in people with overweight and obesity: A review of clinical trial summariesCardiovascular Outcomes of GLP-1-Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.

2 weeks ago • Diabetes, obesity & metabolism

Using Insulin, Semaglutide, and Dapagliflozin Together in Adults with Type 1 Diabetes: Design of an International Phase 3 TrialInsulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.

2 weeks ago • medRxiv : the preprint server for health sciences

GLP Medications and Risk of Severe Long COVID in People with Type 2 DiabetesGLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes Mellitus.

3 weeks ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

How GLP-1 Drugs, Exercise, and Both Together Affect Body Fat and Sugar-Fat Metabolism in Overweight AdultsComparative Efficacy of GLP-1 Receptor Agonists, Exercise, and Their Combination on Body Composition and Glucolipid Metabolism in Adults With Overweight or Obesity: A Network Meta-Analysis of Randomized Controlled Trials.

3 weeks ago • Annals of medicine and surgery (2012)

Genetic Links Between GLP-1 Receptor Activators and Cancer RiskThe association between genetically proxied GLP-1 receptor agonists and cancer risks.

3 weeks ago • The International journal of eating disorders

Activating GLP-1 Receptors Increases Activity-Based Anorexia in MiceGLP-1 Receptor Agonism Exacerbates Activity-Based Anorexia in Mice.

3 weeks ago • Diabetes & vascular disease research

Tirzepatide compared to DPP-4 inhibitors for type 2 diabetes in people with heart failureComparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure.

4 weeks ago • Internal and emergency medicine

GLP-1 Receptor Agonists in Preventing and Treating Cancers Linked to ObesityRole of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer.

1 month ago • Clinical case reports

Small Bowel Blockage Possibly Caused by Tirzepatide in a Patient Without Prior SurgeryTirzepatide-Induced Functional Small Bowel Obstruction in a Surgically Naïve Patient: A Case Report.

1 month ago • Diabetes, obesity & metabolism

Tirzepatide’s real-world effects and safety in type 1 diabetes and obesity, including blood sugar, weight, and heart health markersReal-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers.

2 days ago • Problemy endokrinologii

Semaglutide may cause muscle loss through a hormone and cell growth pathway, affecting muscle sugar use and possibly leading to hard-to-control high blood sugar in type 2 diabetesSemaglutide-Induced Sarcopenia via GLP-1R-mTOR-Satellite Cells Axis and Muscle-Glucose Feedback Loop Potentially Leading to Refractory Hyperglycemia in Type 2 Diabetes: A Case-Driven Hypothesis.

Case Reports

6 days ago • medRxiv : the preprint server for health sciences

Using Negative Controls to Improve Real-World Outcome StudiesDistributional Diagnosis and Calibration with Negative Controls for Outcome-wide Real-world Evidence.

Preprint

1 week ago • Cureus

Blocked Stomach Outlet in an Adult with Ring-Shaped Pancreas After Starting SemaglutideAdult Annular Pancreas Presenting With Gastric Outlet Obstruction Following Semaglutide Initiation: A Case Report.

Case Reports

1 week ago • Cureus

Severe High Blood Calcium in a Patient Using Tirzepatide: Possible Risk FactorsA Case of Severe Hypercalcemia in a Patient Taking Tirzepatide: Potential Risk Factors.

Case Reports

yesterday • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Safety and effectiveness of treatments that activate glucagon-like peptide-1 receptors in people with end-stage kidney diseaseSafety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis.

Article

yesterday • Proceedings of the National Academy of Sciences of the United States of America

Brain hunger neurons needed for weight loss effects of GLP-1 drugs in female miceAgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice.

Article

yesterday • Diabetes, obesity & metabolism

GLP-1 Receptor Agonist Treatment for Obesity in Japan: Effects of Lifestyle Before Treatment, Limited Treatment Time, and Weight Regain After StoppingGLP-1 Receptor Agonist Therapy for Obesity Under Japan's Optimal Use Guideline: A Prospective Real-World Study of Lifestyle Pre-Treatment, Time-Limited Treatment Cap, and Post-Cessation Regain.

Article

2 days ago • Molecular and cellular biochemistry

Liraglutide may improve energy production and gene regulation in diabetic kidney disease through the NQO1/SIRT3 pathwayLiraglutide affects mitochondrial function and histone acetylation through the NQO1/SIRT3 pathway in diabetic kidney disease.

Article

2 days ago • Problemy endokrinologii

Expert agreement on safely using semaglutide and tirzepatide for obesity treatment[Safety Management of Incretin-Based Obesity Therapy: Expert Consensus on the Use of Semaglutide and Tirzepatide].

English Abstract

2 days ago • Clinical nutrition (Edinburgh, Scotland)

Higher blood levels of glucagon-like peptide-1 are linked to feeding problems after traumatic brain injuryElevated plasma glucagon-like Peptide-1 levels are associated with enteral feeding intolerance in traumatic brain injury.

Article

← prevpage 12 of 15next →

GLP-1 Therapies Research Papers